Literature DB >> 25246886

False positive Hepatitis B Surface Antigen due to recent vaccination.

Qudsia Anjum1.   

Abstract

OBJECTIVE: Hepatitis B is the most common viral hepatitis, potentially life threatening, with long term complications. Currently, vaccine is the most effective tool against hepatitis B infection. It is worthwhile mentioning that due to rampant use of hepatitis B vaccine (HBV), there have been concerns about hepatitis B surface antigen (HBsAg) reactivity. This article aims to report the false positive results of HBsAg due to recent HBV among healthy male adults. SUBJECTS AND METHODS: The subjects were selected from a Community Health Center, under the umbrella of a tertiary care hospital, Saudi Arabia. The data was retrieved from electronic medical records maintained at the clinic.
RESULTS: A total of 130 employees were recruited, only 117 records could be retrieved from the system. The mean age of participants was 31.34 ± 12.73 years. The administration of HBV and HBsAg test was performed simultaneously. The lab reported three cases of HBsAg positivity, a false positive result of 2.56%. Repeat testing after one week for HBsAg was negative for the three cases.
CONCLUSION: This study confirmed that HBsAg reactivity might be seen in regular screening programs for healthy adults.

Entities:  

Year:  2014        PMID: 25246886      PMCID: PMC4166991          DOI: 10.12816/0006085

Source DB:  PubMed          Journal:  Int J Health Sci (Qassim)        ISSN: 1658-3639


  16 in total

1.  Prolonged hepatitis B surface antigenemia after vaccination.

Authors:  E R Lunn; B J Hoggarth; W J Cook
Journal:  Pediatrics       Date:  2000-06       Impact factor: 7.124

2.  Induced HBs antigenemia in healthy adults after immunization with two different hepatitis B recombinant vaccines.

Authors:  Masoud Ziaee; Alireza Saádatjoo; Malihe Mohamadpour; Mohammad Hasan Namaei
Journal:  Hepat Mon       Date:  2010-12-01       Impact factor: 0.660

3.  Hepatitis B surface antigenemia in chronic hemodialysis patients: effect of hepatitis B immunization.

Authors:  David Ly; Hal F Yee; Maria Brezina; Paul Martin; Gary Gitnick; Sammy Saab
Journal:  Am J Gastroenterol       Date:  2002-01       Impact factor: 10.864

4.  The test for hepatitis B surface antigen is transiently positive after vaccination with recombinant vaccine.

Authors:  H P Brodersen; B Beckers; H Köhler; C Dahlmanns; L Kruska; D Larbig
Journal:  Nephrol Dial Transplant       Date:  1997-12       Impact factor: 5.992

5.  Hepatitis B surface antigenemia in a newborn infant after vaccination.

Authors:  M Challapalli; V Naidu; D G Cunningham
Journal:  Pediatr Infect Dis J       Date:  1993-05       Impact factor: 2.129

6.  Hepatitis B vaccine as a cause of false positive hepatitis B surface antigen.

Authors:  C Olde; M Garcia
Journal:  J CANNT       Date:  1998

7.  Vaccine-induced hepatitis B surface antigen positivity in adult hemodialysis patients: incidental and surveillance data.

Authors:  L Janzen; G Y Minuk; M Fast; K N Bernstein
Journal:  J Am Soc Nephrol       Date:  1996-08       Impact factor: 10.121

8.  Incidence and duration of hepatitis B surface antigenemia after neonatal hepatitis B immunization.

Authors:  S R Bernstein; P Krieger; B L Puppala; M Costello
Journal:  J Pediatr       Date:  1994-10       Impact factor: 4.406

9.  Hepatitis B surface antigenemia in blood donors following vaccination.

Authors:  B Kloster; R Kramer; T Eastlund; B Grossman; B Zarvan
Journal:  Transfusion       Date:  1995-06       Impact factor: 3.157

10.  Positive hepatitis B surface antigen tests due to recent vaccination: a persistent problem.

Authors:  Carolyn D Rysgaard; Cory S Morris; Denny Drees; Tami Bebber; Scott R Davis; Jeff Kulhavy; Matthew D Krasowski
Journal:  BMC Clin Pathol       Date:  2012-09-24
View more
  2 in total

1.  Prevalence of malaria and hepatitis B among pregnant women in Northern Ghana: Comparing RDTs with PCR.

Authors:  Nsoh Godwin Anabire; Paul Armah Aryee; Abass Abdul-Karim; Issah Bakari Abdulai; Osbourne Quaye; Gordon Akanzuwine Awandare; Gideon Kofi Helegbe
Journal:  PLoS One       Date:  2019-02-06       Impact factor: 3.240

2.  Transient Hepatitis B Surface Antigenemia Following Immunization with Heplisav-B.

Authors:  Cristina Corsini Campioli; Zerelda Esquer Garrigos; Mariam Assi; John Raymond Go; Raymund R Razonable; Elena Beam; Joseph Yao; Nathan W Cummins
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2021-01-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.